Literature DB >> 3592038

Somatization in the community: relationship to disability and use of services.

J I Escobar, J M Golding, R L Hough, M Karno, M A Burnam, K B Wells.   

Abstract

We tested the hypotheses that an abridged somatization construct that we had developed would be associated with use of health services, preferential use of medical over mental health services, and an index of disability. These hypotheses were tested using structured interview data from 3,132 randomly selected community respondents. We found that: respondents meeting criteria for somatization reported a heavier use of health services than non-somatizers; of those respondents meeting criteria for a psychiatric diagnosis, somatizers preferentially used medical over mental health services whereas non-somatizers reported the opposite trend; and somatizers were more likely than non-somatizers to report recent sick leave or restricted activity.

Entities:  

Mesh:

Year:  1987        PMID: 3592038      PMCID: PMC1647204          DOI: 10.2105/ajph.77.7.837

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

1.  Hysteria--the stability and usefulness of clinical criteria. A quantitative study based on a follow-up period of six to eight years in 39 patients.

Authors:  M J PERLEY; S B GUZE
Journal:  N Engl J Med       Date:  1962-03-01       Impact factor: 91.245

2.  Cross-cultural aspects of the somatization trait.

Authors:  J I Escobar
Journal:  Hosp Community Psychiatry       Date:  1987-02

3.  The Spanish Diagnostic Interview Schedule. Reliability and comparison with clinical diagnoses.

Authors:  M A Burnam; M Karno; R L Hough; J I Escobar; A B Forsythe
Journal:  Arch Gen Psychiatry       Date:  1983-11

4.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

5.  The design of the Epidemiologic Catchment Area surveys. The control and measurement of error.

Authors:  W W Eaton; C E Holzer; M Von Korff; J C Anthony; J E Helzer; L George; A Burnam; J H Boyd; L G Kessler; B Z Locke
Journal:  Arch Gen Psychiatry       Date:  1984-10

6.  Psychiatric disorders. A rural/urban comparison.

Authors:  D Blazer; L K George; R Landerman; M Pennybacker; M L Melville; M Woodbury; K G Manton; K Jordan; B Locke
Journal:  Arch Gen Psychiatry       Date:  1985-07

7.  Development of the Spanish-language version of the National Institute of Mental Health Diagnostic Interview Schedule.

Authors:  M Karno; A Burnam; J I Escobar; R L Hough; W W Eaton
Journal:  Arch Gen Psychiatry       Date:  1983-11

8.  Lifetime prevalence of specific psychiatric disorders in three sites.

Authors:  L N Robins; J E Helzer; M M Weissman; H Orvaschel; E Gruenberg; J D Burke; D A Regier
Journal:  Arch Gen Psychiatry       Date:  1984-10

9.  Six-month prevalence of psychiatric disorders in three communities 1980 to 1982.

Authors:  J K Myers; M M Weissman; G L Tischler; C E Holzer; P J Leaf; H Orvaschel; J C Anthony; J H Boyd; J D Burke; M Kramer
Journal:  Arch Gen Psychiatry       Date:  1984-10

10.  Utilization of health and mental health services. Three Epidemiologic Catchment Area sites.

Authors:  S Shapiro; E A Skinner; L G Kessler; M Von Korff; P S German; G L Tischler; P J Leaf; L Benham; L Cottler; D A Regier
Journal:  Arch Gen Psychiatry       Date:  1984-10
View more
  40 in total

1.  Managing future Gulf War Syndromes: international lessons and new models of care.

Authors:  Charles C Engel; Kenneth C Hyams; Ken Scott
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

2.  Racial/ethnic differences in general physical symptoms and medically unexplained physical symptoms: Investigating the role of education.

Authors:  Stella Evangelidou; Amanda NeMoyer; Mario Cruz-Gonzalez; Isabel O'Malley; Margarita Alegría
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2020-03-12

3.  Ethnic differences in somatic symptom reporting in children with asthma and their parents.

Authors:  Juan C Vasquez; Gregory K Fritz; Sheryl J Kopel; Ronald Seifer; Elizabeth L McQuaid; Glorisa Canino
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-08       Impact factor: 8.829

4.  A randomized trial of treatments for high-utilizing somatizing patients.

Authors:  Arthur J Barsky; David K Ahern; Mark R Bauer; Nyryan Nolido; E John Orav
Journal:  J Gen Intern Med       Date:  2013-03-14       Impact factor: 5.128

5.  Prevalence of somatoform pain complaints in the German population.

Authors:  Aike Hessel; Manfred Beutel; Michael Geyer; Jörg Schumacher; Elmar Brähler
Journal:  Psychosoc Med       Date:  2005-03-21

6.  The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge.

Authors:  Rob Hoedeman; Annette H Blankenstein; Boudien Krol; Petra C Koopmans; Johan W Groothoff
Journal:  J Occup Rehabil       Date:  2010-06

7.  The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health.

Authors:  Per Fink; Eva Ørnbøl; Kaj Sparle Christensen
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

8.  Perceived need for care among low-income immigrant and U.S.-born black and Latina women with depression.

Authors:  Erum Nadeem; Jane M Lange; Jeanne Miranda
Journal:  J Womens Health (Larchmt)       Date:  2009-03       Impact factor: 2.681

9.  Somatization in frequent attenders of general practice.

Authors:  P J Portegijs; F G van der Horst; I M Proot; H F Kraan; N C Gunther; J A Knottnerus
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-01       Impact factor: 4.328

10.  Severe MUPS in a sick-listed population: a cross-sectional study on prevalence, recognition, psychiatric co-morbidity and impairment.

Authors:  Rob Hoedeman; Boudien Krol; Nettie Blankenstein; Petra C Koopmans; Johan W Groothoff
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.